Malignancies in patients with primary immunodeficiency due to mutations in NFKB1 or NFKB2

C. Klemann (Speaker), T. Lorenzini (Speaker), R. Kobbe (Speaker), A. Hüfner (Speaker), R. Sherka (Speaker), T. W. Kuijpers (Speaker), P. Tuijnenburg (Speaker), H. Lango Allen (Speaker), J. Thaventhiran (Speaker), M. Cook (Speaker), K. Warnatz (Speaker), R. Ameratunga (Speaker), K. Boztug (Speaker), T. Hirschmugl (Speaker), de Vries, E. (Speaker), J. W. M. van der Meer (Speaker), L. I. Gonzalez-Granado (Speaker), L. M. Allende (Speaker), T. Niehues (Speaker), N. Brauer (Speaker), W. Rae (Speaker), F. Atschekzei (Speaker), R. E. Schmidt (Speaker), L. Alsina (Speaker), M. Piquer-Gibert (Speaker), A. Deyà-Martínez (Speaker), M. R. J. Seppänen (Speaker), M. Fliegauf (Speaker), B. Grimbacher (Speaker)

Activity: Talk or presentation typesOral presentationProfessional

Period18 Sep 201921 Sep 2019
Event titleESID 2019 Focused Meeting : Immunodeficiencies with increased risk of cancer
Event typeConference
LocationBrussels, Belgium
Degree of RecognitionInternational